Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Fuchs

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
MMW Fortschritte Der Medizin|June 27, 2018
[Platelets - what should a GP know about]Roland Fuchs
American Journal of Hematology|January 24, 2015
Cup-like blasts in acute myeloid leukemiaEdgar Jost, Reinhild Herwartz, Mareike Hoß, et al.
Clinical Colorectal Cancer|May 26, 2011
Safe use of FOLFOX in two patients with metastatic colorectal carcinoma and severe hepatic dysfunctionChristoph Roderburg, Nicole do O, Roland Fuchs, et al.
Clinical Case Reports|March 14, 2022
Novel homozygous nonsense mutation in the P5'N-1 coding gene as an alternative cause for hereditary anemia with basophilic stipplingMartin Kirschner, Inga Rebecca Heinen, Steffen Koschmieder, et al.
Annals of Hematology|July 1, 2008
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)Carsten Zwick, Josef Birkmann, Norma Peter, et al.
Blood|August 27, 2005
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study GroupWolfgang Hiddemann, Michael Kneba, Martin Dreyling, et al.
Haematologica|December 6, 2018
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IVChristian Michel, Andreas Burchert, Andreas Hochhaus, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
MMW Fortschritte Der Medizin|June 27, 2018
[Platelets - what should a GP know about]Roland Fuchs
American Journal of Hematology|January 24, 2015
Cup-like blasts in acute myeloid leukemiaEdgar Jost, Reinhild Herwartz, Mareike Hoß, et al.
Clinical Colorectal Cancer|May 26, 2011
Safe use of FOLFOX in two patients with metastatic colorectal carcinoma and severe hepatic dysfunctionChristoph Roderburg, Nicole do O, Roland Fuchs, et al.
Clinical Case Reports|March 14, 2022
Novel homozygous nonsense mutation in the P5'N-1 coding gene as an alternative cause for hereditary anemia with basophilic stipplingMartin Kirschner, Inga Rebecca Heinen, Steffen Koschmieder, et al.
Annals of Hematology|July 1, 2008
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)Carsten Zwick, Josef Birkmann, Norma Peter, et al.
Blood|August 27, 2005
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study GroupWolfgang Hiddemann, Michael Kneba, Martin Dreyling, et al.
Haematologica|December 6, 2018
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IVChristian Michel, Andreas Burchert, Andreas Hochhaus, et al.
Pageof 1